Not a pitch. Just one builder's honest take, written in real time after your message landed.
You said you'd been on my site — figured I'd return the favor and write you something substantive instead of a generic "thanks for connecting." This took ~60 seconds. That's the SideGuy Shareable, by the way — but more on that later. First, the read.
Timing is real. Peptides went from "biohacker fringe" to "your dentist mentions BPC-157" in about 18 months. GLP-1s normalized injectable wellness. The category is now socially permissible — that wall is down.
"Plan optimization" framing is sharp. You're not pitching as a pharmacy or a clinic — you're pitching as the layer above. That's the right move because the pharmacy/compound-source layer is going to commoditize fast (it always does). The optimization layer captures the relationship and the recurring revenue.
Your personal credibility is the moat. Harvard + Stanford + 3x Ironman is a stack of trust signals that's almost impossible to fake — and it's exactly what a wellness buyer needs to see before they trust a peptide protocol. You ARE the proof. Don't undersell that on the site.
FDA + state regulatory. Peptides are still a gray area. BPC-157, TB-500, others are research compounds. Compound pharmacies handle most prescriptions. The DEA and FDA periodically tighten — the moat is operational (relationships with compliant compounders) more than tech. The smartest competitors are building the legal/comp moat, not just the AI layer.
Education load on the consumer. Most prospects don't know what BPC-157 is, can't distinguish from TB-500, don't know which protocol fits their goal. The AI helps — but the EDUCATIONAL onboarding is where most wellness brands lose people. If the first 5 minutes don't make someone smarter, they bounce.
Crowded entrants. Function Health, Lifeforce, Hone Health, Henry, Hims, dozens of new D2C peptide brands. The category is loud now. Differentiation isn't "AI-powered" anymore — that's table stakes. The wedge is probably tighter (e.g., post-surgery recovery, athlete-specific, women's longevity).
1. What's the AI actually doing? Protocol design from intake data? Real-time biomarker tracking? Reorder prediction? They're very different products under one phrase.
2. Compound pharmacy partner — do you have a primary, or are you network-agnostic?
3. Are you targeting the optimization audience (peak performers) or the recovery audience (post-injury, post-procedure)? Different funnels, different LTV.
Tony — the page you're reading right now took me 60 seconds to make after your message hit. That's a SideGuy Shareable: a real public URL, no login, no platform, mobile-first, on the open web. I do them for $100 each, same-day. Most agency proposals and wellness landing pages I see should be these instead of PDFs and Notion shares.
If LongevityPlan.AI ever needs custom landing pages per launch, per cohort, per partner — that's my lane. But this isn't a pitch. Mostly I just appreciated you reaching out, wanted to give you something real back, and figured this was more useful than "thanks for connecting."
If any of the read above is wrong, would love to hear it. If something's right, would love to hear that too.
Don't see what you were looking for?
Text PJ a sentence about what you actually need — I'll build you a free custom shareable on the house. No email, no funnel, no SOW.
📲 Text PJ — free shareable